AMERICAN INTERNATIONAL GROUP, INC. - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2022$46,000
-11.5%
16,026
-6.6%
0.00%
Q4 2021$52,000
-58.1%
17,154
-2.9%
0.00%
-100.0%
Q3 2021$124,000
-24.4%
17,668
-1.3%
0.00%0.0%
Q2 2021$164,000
-6.3%
17,903
-0.4%
0.00%0.0%
Q1 2021$175,000
-4.9%
17,982
+0.3%
0.00%0.0%
Q4 2020$184,0000.0%17,934
-1.8%
0.00%0.0%
Q3 2020$184,000
-5.6%
18,264
-2.2%
0.00%0.0%
Q2 2020$195,000
+26.6%
18,680
+2.6%
0.00%0.0%
Q1 2020$154,000
-8.9%
18,210
-5.5%
0.00%0.0%
Q4 2019$169,000
-19.1%
19,262
-0.8%
0.00%0.0%
Q3 2019$209,000
-16.1%
19,424
-0.7%
0.00%0.0%
Q2 2019$249,000
-65.4%
19,559
+5.3%
0.00%
-66.7%
Q1 2019$720,000
+84.6%
18,569
-3.1%
0.00%
+50.0%
Q4 2018$390,000
-56.0%
19,172
-0.8%
0.00%
-33.3%
Q3 2018$886,000
-21.0%
19,319
+1.8%
0.00%
-25.0%
Q2 2018$1,122,000
-11.6%
18,971
+1.8%
0.00%0.0%
Q1 2018$1,269,000
-33.7%
18,644
-3.7%
0.00%
-33.3%
Q4 2017$1,913,000
-17.1%
19,353
+0.5%
0.01%
-25.0%
Q3 2017$2,307,000
+48.1%
19,262
+8.1%
0.01%
+33.3%
Q2 2017$1,558,000
+147.3%
17,821
+5.3%
0.01%
+200.0%
Q1 2017$630,000
+44.5%
16,931
+19.2%
0.00%0.0%
Q4 2016$436,000
-100.0%
14,198
-0.3%
0.00%
-50.0%
Q3 2016$954,457,000
+125.4%
14,235
+0.1%
0.00%
+100.0%
Q2 2016$423,435,000
+2128.6%
14,214
+2110.6%
0.00%
Q1 2016$19,000,000
-62.0%
643
+1.7%
0.00%
Q4 2015$50,000,000
+111011.1%
632
+4.1%
0.00%
Q3 2015$45,000
-99.9%
607
+10.2%
0.00%
Q2 2015$64,329,000
-98.1%
551
-96.2%
0.00%
-100.0%
Q1 2015$3,446,734,000
+24.7%
14,5980.0%0.01%
+16.7%
Q4 2014$2,762,963,000
-23.7%
14,598
-3.8%
0.01%
-25.0%
Q3 2014$3,620,538,000
+261.2%
15,176
-0.1%
0.02%
+300.0%
Q2 2014$1,002,342,000
-36.1%
15,187
+0.8%
0.00%
-42.9%
Q1 2014$1,568,453,000
+3.1%
15,061
+2.5%
0.01%0.0%
Q4 2013$1,521,787,000
+91.0%
14,699
-1.0%
0.01%
+75.0%
Q3 2013$796,636,00014,8460.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 1,792,114$5,108,0002.15%
Camber Capital Management LP 4,235,000$12,070,0000.52%
Kynam Capital Management, LP 579,915$1,653,0000.42%
GLOBEFLEX CAPITAL L P 419,322$1,195,0000.29%
Eversept Partners, LP 1,435,077$4,089,9690.29%
ARMISTICE CAPITAL, LLC 1,500,000$4,275,0000.08%
RICE HALL JAMES & ASSOCIATES, LLC 506,066$1,442,0000.07%
XTX Topco Ltd 36,130$103,0000.04%
State of Wyoming 20,732$59,0000.04%
Patriot Financial Group Insurance Agency, LLC 55,500$158,0000.03%
View complete list of PUMA BIOTECHNOLOGY INC shareholders